Fig. 1 · Structure
Documents & Downloads
ABT-202
Drug Derivative
ABT-202 is a potent drug derivative that functions as a selective inhibitor of the anti-apoptotic Bcl-2 family proteins. This compound promotes apoptosis in cancer cells, making it a valuable tool for investigating cancer therapeutic mechanisms. Its specificity towards Bcl-2-related pathways supports research in apoptosis regulation and potential cancer treatment strategies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 309959-34-0 |
| Applications | Drug Derivative |
| Formula | C9H13N3 |
| Molecular Weight | 163.22 |
| SMILES | N[C@H]1CN(C2=CC=CN=C2)CC1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.